Allspring Global Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$339K Buy
82,315
+3,122
+4% +$12K ﹤0.01% 1548
2026
Q1
$309K Buy
+79,193
New +$325K ﹤0.01% 1519
2025
Q2
Sell
-36,316
Closed -$53.4K 1715
2025
Q1
$53.4K Sell
36,316
-5,570
-13% -$13.3K ﹤0.01% 1705
2024
Q4
$181K Sell
41,886
-3,311
-7% -$13.4K ﹤0.01% 1681
2024
Q3
$186K Sell
45,197
-5,243
-10% -$28.2K ﹤0.01% 1686
2024
Q2
$329K Sell
50,440
-28,921
-36% -$205K ﹤0.01% 1602
2024
Q1
$691K Buy
79,361
+30,745
+63% +$373K ﹤0.01% 1453
2023
Q4
$556K Buy
48,616
+42,091
+645% +$416K ﹤0.01% 1470
2023
Q3
$62.8K Sell
6,525
-125,401
-95% -$1.23M ﹤0.01% 2185
2023
Q2
$1.4M Sell
131,926
-141,772
-52% -$1.52M ﹤0.01% 1336
2023
Q1
$2.88M Buy
273,698
+95,111
+53% +$1.07M ﹤0.01% 1145
2022
Q4
$2.21M Sell
178,587
-114,617
-39% -$1.3M ﹤0.01% 1210
2022
Q3
$3.04M Buy
293,204
+11,484
+4% +$130K 0.01% 1111
2022
Q2
$3.25M Sell
281,720
-662,218
-70% -$7.8M 0.01% 1106
2022
Q1
$11.9M Buy
943,938
+1,890
+0.2% +$21.7K 0.02% 826
2021
Q4
$11M Buy
+942,048
New +$11.6M 0.01% 894

Other funds holding IRWD

Allspring Global Investments's IRWD Position: Q2 2026 in Review

Allspring Global Investments increased its Ironwood Pharmaceuticals (IRWD) stake by 3.9% in Q2 2026, buying an estimated $12K and bringing the position to 82,315 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

Allspring Global Investments first reported a position in IRWD in Q4 2021 and has held it in 16 quarters since. The position peaked at $11.9M in Q1 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Allspring Global Investments held 82,315 shares of Ironwood Pharmaceuticals worth $339K as of Q2 2026.
  • Allspring Global Investments bought 3,122 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $12K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1548 holding.
  • Allspring Global Investments first reported a position in Ironwood Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
  • Allspring Global Investments's Ironwood Pharmaceuticals position peaked at $11.9M in Q1 2022.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.